drugs
The latest news on drugs
Agency advisers say there's not enough data in company trials on benefit for high-risk patients
You really are what you eat; are you sitting yourself to death?
Agency's advisory panel to vote on whether Xarelto should be approved for treating acute coronary syndrome
But researchers say it's not clear how they're linked
Undetected disease can lead to cirrhosis, liver cancer, agency notes
Drug helps prevent deadly clots
In study, one-third benefited from taking Zytiga plus hormone therapy for 6 months before surgery
Experts stress that information needs to be passed on after cancer treatment ends.
Yale research shows FDA ahead of other regulators in the approval process
Many of the study participants are genetically prone to the disease
